Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endosomal proteolysis and MHC class II function

H A Chapman1

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. hchapman@rics.bwh.harvard.edu

Current Opinion in Immunology
|April 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Oncogene·2012
Same author

Hearts and minds: Coordination of neurocognitive and cardiovascular regulation in children and adolescents.

Biological psychology·2010
Same author

In bad taste: evidence for the oral origins of moral disgust.

Science (New York, N.Y.)·2009
Same author

Comorbidity on disorders with loss of impulse-control: pathological gambling, addictions and personality disorders.

Actas espanolas de psiquiatria·2006
Same author

Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

Thorax·2004
Same author

Deficiency of the cysteine protease cathepsin S impairs microvessel growth.

Circulation research·2003
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

The invariant chain guides MHC class II assembly and trafficking. Cysteine proteases like cathepsins S and L are crucial for invariant chain degradation, enabling antigen loading onto MHC class II molecules.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Newly synthesized MHC class II molecules require association with the invariant chain for proper folding, assembly, and intracellular trafficking.
  • The invariant chain prevents premature peptide binding to MHC class II molecules in the endoplasmic reticulum.

Purpose of the Study:

  • To elucidate the role of invariant chain processing in MHC class II peptide loading.
  • To investigate the function of specific cysteine proteases in regulating antigen presentation.

Main Methods:

  • Studies involving protein interactions and cellular trafficking pathways.
  • Analysis of proteolytic processing of the invariant chain.
  • Investigating the activity of cysteine proteases such as cathepsins S and L.

Related Experiment Videos

Main Results:

  • The invariant chain acts as a chaperone, facilitating MHC class II assembly and transport.
  • Concurrent proteolytic processing of the invariant chain and endocytosed antigens is essential for efficient MHC class II peptide loading.
  • Cathepsins S and L play critical roles in degrading the invariant chain.

Conclusions:

  • Specific cysteine proteases are key regulators of invariant chain degradation.
  • These proteases control the convergence of processed antigens and MHC class II dimers, enabling effective antigen presentation.